Atrial Fibrillation (Afib) is a common, yet serious heart condition that requires proper diagnosis and management strategies.

A risk-assessment tool incorporating NT-proBNP and high-sensitivity troponin performs better than clinical scores for ...

Opens in a new tab or window For patients with HIV and atrial fibrillation, this study found that apixaban was associated with less bleeding when compared with warfarin and rivaroxaban.

Opens in a new tab or window A population-based cohort study found an association between bleeding events in Afib patients on oral anticoagulation and cancer diagnoses. In cases where cancer was ...

US and European guidelines for atrial fibrillation differ in subtle but important ways that are swaying treatment decisions.

They also base their decisions to stop anticoagulants on past experiences with people who took the anticoagulant warfarin, Mitchell said. Up until 2012, warfarin was the only option to treat Afib.

A new study from the University of Bath has found that for older adults with atrial fibrillation (AF), stopping blood ...

There is an apparent underuse of warfarin in elderly patients with AF, as there is inconsistency in opinion among clinicians about who should receive anticoagulation. The risks of warfarin are ...

With no differences between single or dual antiplatelet therapy or anticoagulants at 6 months, an RCT is warranted for ...

Persistent atrial fibrillation (AFib) has long been a challenging cardiac condition to treat. Affecting millions worldwide, its complexities often stump ...

The fields of pharmacology and dentistry have long been intertwined. Medications prescribed for heart conditions — such as ...

The following is a summary of “Anticoagulation and Antiplatelet Therapy for Atrial Fibrillation and Stable Coronary Disease: ...